SA
Shailesh Anand Agarwal
About Shailesh Anand Agarwal
Data last updated:
Shailesh Anand Agarwal is a Director at Aps Biotech Private Limited (since 2005). The company operates in Pharma. Aps Biotech Private Limited reported revenue of ₹8.72 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aps Biotech Private Limited U24230UR2005PTC007161 | Director | 11 Oct 2005 | 2005 | ₹8.72 Cr (FY 2024) | Active |
Board colleagues of Shailesh Anand Agarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anand Kumar Agarwal | 07126094 | Aps Biotech Private Limited | Director |
| Anil Narnoli | 00939773 | Aps Biotech Private Limited | Director |
| Mahesh Kumar Megotia | 01833594 | Aps Biotech Private Limited | Director |
| Pawankumar Nathmal Agarwal | 00111856 | Aps Biotech Private Limited | Director |
| Prem Kumar Megotia | 07126044 | Aps Biotech Private Limited | Director |
| Sunil Narnoli | 07127429 | Aps Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shailesh Anand Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shailesh Anand Agarwal
Shailesh Anand Agarwal currently holds 1 directorship: Aps Biotech Private Limited (Director, since 11 Oct 2005, revenue ₹8.72 Cr (FY 2024)).
Shailesh Anand Agarwal was first appointed on 11 Oct 2005 as Director at Aps Biotech Private Limited.
The current boards of Shailesh Anand Agarwal's companies include Anand Kumar Agarwal (Aps Biotech Private Limited), Anil Narnoli (Aps Biotech Private Limited), Mahesh Kumar Megotia (Aps Biotech Private Limited), Pawankumar Nathmal Agarwal (Aps Biotech Private Limited), Prem Kumar Megotia (Aps Biotech Private Limited), Sunil Narnoli (Aps Biotech Private Limited).